Y
Yu Huang
Researcher at Chinese Academy of Sciences
Publications - 1798
Citations - 114451
Yu Huang is an academic researcher from Chinese Academy of Sciences. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 136, co-authored 1492 publications receiving 89209 citations. Previous affiliations of Yu Huang include The Chinese University of Hong Kong & Samsung.
Papers
More filters
Journal ArticleDOI
Endothelium-dependent contraction and direct relaxation induced by baicalein in rat mesenteric artery.
TL;DR: Results indicate that baicalein at low concentrations caused a contractile response and inhibited the endothelium-dependent relaxation, probably through inhibition of endothelial nitric oxide (NO) formation/release.
Journal ArticleDOI
Inactivation of the E-Prostanoid 3 Receptor Attenuates the Angiotensin II Pressor Response via Decreasing Arterial Contractility
Lihong Chen,Yifei Miao,Yahua Zhang,Dou Dou,Limei Liu,Xiao Yu Tian,Guangrui Yang,Dan Pu,Xiaoyan Zhang,Jihong Kang,Yuansheng Gao,Shiqiang Wang,Matthew D. Breyer,Nanping Wang,Yi Zhu,Yu Huang,Richard M. Breyer,Youfei Guan +17 more
TL;DR: Activation of the EP3 receptor raises baseline blood pressure and contributes to Ang II–dependent hypertension at least partially via enhancing Ca2+ sensitivity and intracellular calcium concentration in vascular smooth muscle cells.
Journal ArticleDOI
Mechanism of non-capacitative Ca2+ influx in response to bradykinin in vascular endothelial cells.
Pan Cheung Leung,Kwong Tai Cheng,Cuiling Liu,Wing-Tai Cheung,Hiu Yee Kwan,Kin Ling Lau,Yu Huang,Xiaoqiang Yao +7 more
TL;DR: The data suggest that bradykinin-induced non-CCE is mediated via the B2-PLC pathway, and that DAG may be involved in this process.
Journal Article
Hydrogen sulfide: potent regulator of vascular tone and stimulator of angiogenesis.
TL;DR: Recent findings which are summarized in this paper provide new insights into molecular mechanisms of hydrogen sulfide that are crucial for understanding vascular dysfunction in cardiovascular disease and possibly angiogenesis.
Journal ArticleDOI
The peroxisome proliferator-activated receptors in cardiovascular diseases: experimental benefits and clinical challenges.
TL;DR: The cardiovascular effects of PPARs are reviewed, with emphasis on the therapeutic potential ofPPAR agonists in combating metabolic vascular diseases.